Health

Psilocybin Rewires Brain Connections To Help Alleviate Depression

Brain Network Artist Concept

Psilocybin fosters greater connections between different regions of the brain in depressed people, freeing them up from long-held patterns of rumination and excessive self-focus, according to a new study by scientists at UC San Francisco and Imperial College London.

The discovery points toward a general mechanism through which psychedelics may be acting therapeutically on the brain to alleviate depression and possibly other psychiatric conditions that are marked by fixed patterns of thinking.

Scientists analyzed fMRI brain scans from nearly 60 people who had participated in two psilocybin trials. In the first one, all the participants had treatment-resistant depression and knew they were being given psilocybin. In the second one, the participants were depressed but not as severely, and they were not told whether they had been given psilocybin or a placebo that turned out to be escitalopram, an SSRI antidepressant. In addition to the drugs, all the participants received the same type of psychotherapy.

The scans, which were done before and after treatment, showed the psilocybin treatment reduced connections within brain areas that are tightly connected in depression, including the default mode, salience, and executive networks, and increased connections to other regions of the brain that had not been well integrated. 

Participants were also less emotionally avoidant and their cognitive functioning got better. The improvement in their depressive symptoms correlated with changes to their brains, and these changes lasted until the study ended three weeks after the second psilocybin dose. No such changes were seen in the brains of those who received escitalopram, suggesting that psilocybin acts differently on the brain than SSRIs.

Psilocybin and other serotonergic psychedelics like ayahuasca affect 5-HT2A receptors, which are plentiful in brain networks that become overactive in depression. One hypothesis is that the drugs briefly disrupt these connections, giving them a chance to reform in new ways in the ensuing days and weeks. 

“In previous studies we had seen a similar effect in the brain when people were scanned whilst on a psychedelic, but here we’re seeing it weeks after treatment for depression, which suggests a carry-over of the acute drug action,” said Robin Carhart-Harris, PhD, who directs the Neuroscape Psychedelics Division at UCSF and is the senior author of the study, which appears today (April 11, 2022) in Nature Medicine.

“We don’t yet know how long the changes in brain activity seen with psilocybin therapy last, and we need to do more research to understand this,” said Carhart-Harris, who is the Ralph Metzner Distinguished Professor of Neurology, Psychiatry, and Behavioral Sciences and a member of the UCSF Weill Institute for Neurosciences. “We do know that some people relapse, and it may be that after a while their brains revert to the rigid patterns of activity we see in depression.”

The authors caution that while these findings are encouraging, patients with depression should not attempt to self-medicate with psilocybin. The trials took place under controlled, clinical conditions, using a regulated dose formulated in a laboratory, and involved extensive psychological support before, during, and after dosing.  

But the study points to a mechanism that, if it holds up, may explain both how psilocybin helps to alleviate depression and potentially other debilitating psychiatric conditions.

“For the first time we find that psilocybin works differently from conventional antidepressants – making the brain more flexible and fluid, and less entrenched in the negative thinking patterns associated with depression,” said David Nutt, DM, head of the Imperial Centre for Psychedelic Research. “This supports our initial predictions and confirms psilocybin could be a real alternative approach to depression treatments.”

Disclosures, as well as the full list of authors and funding are available in the paper.

For more on this research, see Psychedelic Magic Mushroom Compound Psilocybin Rewires the Brain for People With Depression.

Reference: “Increased global integration in the brain after psilocybin therapy for depression” by Richard E. Daws, Christopher Timmermann, Bruna Giribaldi, James D. Sexton, Matthew B. Wall, David Erritzoe, Leor Roseman, David Nutt and Robin Carhart-Harris, 11 April 2022, Nature Medicine.
DOI: 10.1038/s41591-022-01744-z

Share

View Comments

  • Me interesa saber si la psilocibina también podría ayudar en los problemas con parkinson

  • These kinds of articles are so helpful and frustrating. Here is this possible treatment for people who are suffering a terrible disease, but its illegal and shouldn't be tried ok your own. Psychedelics need to be legalized/decriminalized and studied. People need access to this medicine. It is a matter of life and death.

    • Some cities, such as Oakland, have decriminalized psilocybin. Who knows if more will follow... as is usually the case, scientists are saying that more studies need to be done to make any definitive conclusions.

  • Wait, escitalopram is most definitely NOT a placebo. It's an antidepressant. So they weren't comparing psilocybin to a baseline, they were comparing it to another common treatment. And the other group was not in a double blind study? This doesn't pass the sniff test for good experiment design.

    • It needs work. Risperidone (5HT2A/DRD2) and buspirone (5HT1A) would have been better cross-comparisons if tightly targeted medicines were to be used, especially for tardive dyskenesia which tends to occur in a lot of pharmaceuticals with DRD2 antagonist properties. No crack dancing allowed.

Recent Posts

NASA’s Juno Spacecraft Captures Closest View of Jupiter’s Icy Moon Europa in 22 Years

Observations from the Juno spacecraft’s close pass of the icy moon provided the first close-up…

September 30, 2022

Russian Cosmonauts Undock From Space Station and Return to Earth

Yesterday, September 29, the Soyuz spacecraft undocked from the International Space Station (ISS) at 3:34…

September 30, 2022

Ancestral Heritage and Cancer: New Connection Discovered

The study also identified a new prostate cancer taxonomy. Two groundbreaking studies recently published in the…

September 30, 2022

Scientists Discover the Secret to Making Food Seem Tastier

How does color impact how you perceive food? According to recent research, a restaurant may…

September 30, 2022

Celebrate “International Observe the Moon Night 2022” With NASA

NASA invites the public to participate in the celebration of "International Observe the Moon Night"…

September 30, 2022

Increase Happiness and Reduce Stress – Researchers Recommend Replacing Social Media With This Type of Activity

The study recommends replacing social media with physical activity.  Your mental health will be greatly…

September 30, 2022